Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats

Linda Paulson, Peter Martin, Anders Persson, Carol L. Nilsson, Elisabeth Ljung, Ann Westman-Brinkmalm, Peter S. Eriksson, Kaj Blennow, Pia Davidsson

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

cDNA microarrays and two-dimensional gel-electrophoresis in combination with mass spectrometry, were used to screen alterations in mRNA and protein levels, respectively, in cerebral cortex of MK-801-treated rats. The rats were divided in two groups; group 1 (short-term treated) and group 2 (long-term treated). In group 1, four genes were up-regulated and five down-regulated. In group 2, seven genes were up-regulated and six down-regulated. In group 1, the levels of one protein was increased and eight proteins reduced. In group 2, the levels of two proteins were increased and four proteins reduced. Several of the altered genes (casein kinase 2, glutamic acid decarboxylase, synaptotagmin, gamma aminobutyric acid [GABA] transporter, creatine kinase, and cytochrome c oxidase) and proteins (superoxide dismutase, hsp 60, hsp 72 and γ-enolase) have previously been connected to schizophrenia. Alterations of the genes (microglobulin, c-jun proto-oncogene, 40S ribosomal protein S19, adenosine diphosphate (ADP)ribosylation factors, platelet-derived growth factor, fructose-bisphophate aldolase A, and myelin proteolipid) and the proteins (stathmin, H+-transp. Adenosine triphosphate (ATP) synthase, pyruvate dehydrogenase, β-actin and α-enolase), have not, to our knowledge, earlier been implicated in schizophrenia pathology. Overall, these results with a combined approach of genomics and proteomics add to the validity of subchronic N-methylD-aspartate (NMDA)-receptor antagonist treatment as an animal model of schizophrenia.

Original languageEnglish (US)
Pages (from-to)526-533
Number of pages8
JournalJournal of Neuroscience Research
Volume71
Issue number4
DOIs
StatePublished - Feb 15 2003
Externally publishedYes

Fingerprint

Dizocilpine Maleate
Proteome
Cerebral Cortex
Genome
Schizophrenia
Proteins
Phosphopyruvate Hydratase
Genes
Pyruvate Synthase
Myelin Proteolipid Protein
Stathmin
Synaptotagmins
jun Genes
Casein Kinase II
Fructose-Bisphosphate Aldolase
Glutamate Decarboxylase
Platelet-Derived Growth Factor
Electrophoresis, Gel, Two-Dimensional
Electron Transport Complex IV
Creatine Kinase

Keywords

  • Brain
  • cDNA microarray
  • MK-801
  • Rat
  • Two-dimensional gel electrophoresis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Paulson, L., Martin, P., Persson, A., Nilsson, C. L., Ljung, E., Westman-Brinkmalm, A., ... Davidsson, P. (2003). Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats. Journal of Neuroscience Research, 71(4), 526-533. https://doi.org/10.1002/jnr.10509

Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats. / Paulson, Linda; Martin, Peter; Persson, Anders; Nilsson, Carol L.; Ljung, Elisabeth; Westman-Brinkmalm, Ann; Eriksson, Peter S.; Blennow, Kaj; Davidsson, Pia.

In: Journal of Neuroscience Research, Vol. 71, No. 4, 15.02.2003, p. 526-533.

Research output: Contribution to journalArticle

Paulson, L, Martin, P, Persson, A, Nilsson, CL, Ljung, E, Westman-Brinkmalm, A, Eriksson, PS, Blennow, K & Davidsson, P 2003, 'Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats', Journal of Neuroscience Research, vol. 71, no. 4, pp. 526-533. https://doi.org/10.1002/jnr.10509
Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A et al. Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats. Journal of Neuroscience Research. 2003 Feb 15;71(4):526-533. https://doi.org/10.1002/jnr.10509
Paulson, Linda ; Martin, Peter ; Persson, Anders ; Nilsson, Carol L. ; Ljung, Elisabeth ; Westman-Brinkmalm, Ann ; Eriksson, Peter S. ; Blennow, Kaj ; Davidsson, Pia. / Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats. In: Journal of Neuroscience Research. 2003 ; Vol. 71, No. 4. pp. 526-533.
@article{fe69cf1b1a9841c9963898504bf95125,
title = "Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats",
abstract = "cDNA microarrays and two-dimensional gel-electrophoresis in combination with mass spectrometry, were used to screen alterations in mRNA and protein levels, respectively, in cerebral cortex of MK-801-treated rats. The rats were divided in two groups; group 1 (short-term treated) and group 2 (long-term treated). In group 1, four genes were up-regulated and five down-regulated. In group 2, seven genes were up-regulated and six down-regulated. In group 1, the levels of one protein was increased and eight proteins reduced. In group 2, the levels of two proteins were increased and four proteins reduced. Several of the altered genes (casein kinase 2, glutamic acid decarboxylase, synaptotagmin, gamma aminobutyric acid [GABA] transporter, creatine kinase, and cytochrome c oxidase) and proteins (superoxide dismutase, hsp 60, hsp 72 and γ-enolase) have previously been connected to schizophrenia. Alterations of the genes (microglobulin, c-jun proto-oncogene, 40S ribosomal protein S19, adenosine diphosphate (ADP)ribosylation factors, platelet-derived growth factor, fructose-bisphophate aldolase A, and myelin proteolipid) and the proteins (stathmin, H+-transp. Adenosine triphosphate (ATP) synthase, pyruvate dehydrogenase, β-actin and α-enolase), have not, to our knowledge, earlier been implicated in schizophrenia pathology. Overall, these results with a combined approach of genomics and proteomics add to the validity of subchronic N-methylD-aspartate (NMDA)-receptor antagonist treatment as an animal model of schizophrenia.",
keywords = "Brain, cDNA microarray, MK-801, Rat, Two-dimensional gel electrophoresis",
author = "Linda Paulson and Peter Martin and Anders Persson and Nilsson, {Carol L.} and Elisabeth Ljung and Ann Westman-Brinkmalm and Eriksson, {Peter S.} and Kaj Blennow and Pia Davidsson",
year = "2003",
month = "2",
day = "15",
doi = "10.1002/jnr.10509",
language = "English (US)",
volume = "71",
pages = "526--533",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Comparative genome- and proteome analysis of cerebral cortex from MK-801 treated rats

AU - Paulson, Linda

AU - Martin, Peter

AU - Persson, Anders

AU - Nilsson, Carol L.

AU - Ljung, Elisabeth

AU - Westman-Brinkmalm, Ann

AU - Eriksson, Peter S.

AU - Blennow, Kaj

AU - Davidsson, Pia

PY - 2003/2/15

Y1 - 2003/2/15

N2 - cDNA microarrays and two-dimensional gel-electrophoresis in combination with mass spectrometry, were used to screen alterations in mRNA and protein levels, respectively, in cerebral cortex of MK-801-treated rats. The rats were divided in two groups; group 1 (short-term treated) and group 2 (long-term treated). In group 1, four genes were up-regulated and five down-regulated. In group 2, seven genes were up-regulated and six down-regulated. In group 1, the levels of one protein was increased and eight proteins reduced. In group 2, the levels of two proteins were increased and four proteins reduced. Several of the altered genes (casein kinase 2, glutamic acid decarboxylase, synaptotagmin, gamma aminobutyric acid [GABA] transporter, creatine kinase, and cytochrome c oxidase) and proteins (superoxide dismutase, hsp 60, hsp 72 and γ-enolase) have previously been connected to schizophrenia. Alterations of the genes (microglobulin, c-jun proto-oncogene, 40S ribosomal protein S19, adenosine diphosphate (ADP)ribosylation factors, platelet-derived growth factor, fructose-bisphophate aldolase A, and myelin proteolipid) and the proteins (stathmin, H+-transp. Adenosine triphosphate (ATP) synthase, pyruvate dehydrogenase, β-actin and α-enolase), have not, to our knowledge, earlier been implicated in schizophrenia pathology. Overall, these results with a combined approach of genomics and proteomics add to the validity of subchronic N-methylD-aspartate (NMDA)-receptor antagonist treatment as an animal model of schizophrenia.

AB - cDNA microarrays and two-dimensional gel-electrophoresis in combination with mass spectrometry, were used to screen alterations in mRNA and protein levels, respectively, in cerebral cortex of MK-801-treated rats. The rats were divided in two groups; group 1 (short-term treated) and group 2 (long-term treated). In group 1, four genes were up-regulated and five down-regulated. In group 2, seven genes were up-regulated and six down-regulated. In group 1, the levels of one protein was increased and eight proteins reduced. In group 2, the levels of two proteins were increased and four proteins reduced. Several of the altered genes (casein kinase 2, glutamic acid decarboxylase, synaptotagmin, gamma aminobutyric acid [GABA] transporter, creatine kinase, and cytochrome c oxidase) and proteins (superoxide dismutase, hsp 60, hsp 72 and γ-enolase) have previously been connected to schizophrenia. Alterations of the genes (microglobulin, c-jun proto-oncogene, 40S ribosomal protein S19, adenosine diphosphate (ADP)ribosylation factors, platelet-derived growth factor, fructose-bisphophate aldolase A, and myelin proteolipid) and the proteins (stathmin, H+-transp. Adenosine triphosphate (ATP) synthase, pyruvate dehydrogenase, β-actin and α-enolase), have not, to our knowledge, earlier been implicated in schizophrenia pathology. Overall, these results with a combined approach of genomics and proteomics add to the validity of subchronic N-methylD-aspartate (NMDA)-receptor antagonist treatment as an animal model of schizophrenia.

KW - Brain

KW - cDNA microarray

KW - MK-801

KW - Rat

KW - Two-dimensional gel electrophoresis

UR - http://www.scopus.com/inward/record.url?scp=0037441519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037441519&partnerID=8YFLogxK

U2 - 10.1002/jnr.10509

DO - 10.1002/jnr.10509

M3 - Article

VL - 71

SP - 526

EP - 533

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 4

ER -